Nanosystems for the oral administration of alkyl-lysophospholipid anti-tumor agents: development of lipid nanotransporters and preclinical studies
Edelfosine is a synthetic alkyl ether phospholipid that represents a promising class of antitumor agents, with limited side effects but presenting a low oral bioavailability. In order to solve this drawback, edelfosine has been entrapped into lipid nanoparticles (LN). The nanosystems have been prep...
Main Authors: | Estella-Hermoso-de-Mendoza, A. (Ander), Blanco-Prieto, M.J. (María José) |
---|---|
Format: | info:eu-repo/semantics/doctoralThesis |
Language: | eng |
Published: |
Servicio de Publicaciones de la Universidad de Navarra
2011
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/17631 |
Similar Items
-
Alquil-lysophospholipids and cancer: development of lipid nanoparticles for oral administration and preclinical studies
by: Lasa-Saracibar, B. (Beatriz), et al.
Published: (2016) -
Zein based-nanoparticles improve the oral bioavailability of resveratrol and its anti-inflammatory effects in a mouse model of endotoxic shock
by: Peñalva, R. (Rebeca), et al.
Published: (2016) -
Quantitative determination of the antitumor alkyl ether phospholipid edelfosine by reversed-phase liquid chromatography-electrospray mass spectrometry: application to cell uptake studies and characterization of drug delivery systems.
by: Blanco-Prieto, M.J. (María José), et al.
Published: (2012) -
Extraction of microalgal lipids and the influence of polar lipids on biodiesel production by lipase-catalyzed transesterification
by: Navarro López, Elvira, et al.
Published: (2024) -
Nanomedicines for Pediatric Cancers
by: Rodriguez-Nogales, C. (Carlos), et al.
Published: (2024)